Physician

Amir Karam Issa, MD

According to 2025 Medicare claims, Amir Issa, MD (NPI: 1386110799) practices interventional pain management (ipm) in the Newark, NJ market, with the plurality of this provider's patient population coming from Essex, NJ. This provider's primary affiliated billing organization is CURA MEDICAL GROUP LLC (NPI: 1154068401) and primary practice location at 07470-3233.

Issa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 57 traditional Medicare patients, billed 517 HCPCS/CPT codes, and received $97,551 in Medicare payments. The top billing code was 93970 (Ultrasound study of arm or leg veins with compression and maneuvers). Part D data shows 51 prescription claims across 31 beneficiaries totaling $934 in drug costs, led by Methylprednisolone (Methylprednisolone). Open Payments data shows 4 records totaling $73. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,663 to $97,551. In contrast, Part D prescription costs have fallen sharply in recent years, from $11,115 to $934. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$49K$98K2019 Medicare payment: $4,663 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $7,884 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $12,408 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $11,179 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $43,647 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $97,551 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20192780$4,663
202050138$7,884
202143163$12,408
202240150$11,179
202332206$43,647
202457517$97,551

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$46K$92K2019 Drug cost: $11,115 (USD; Tot_Drug_Cst)2020 Drug cost: $33,705 (USD; Tot_Drug_Cst)2021 Drug cost: $92,036 (USD; Tot_Drug_Cst)2022 Drug cost: $80,740 (USD; Tot_Drug_Cst)2023 Drug cost: $7,817 (USD; Tot_Drug_Cst)2024 Drug cost: $934 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201940122$11,115
2020106604$33,705
202191950$92,036
202285838$80,740
202338100$7,817
20243151$934

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
93970Ultrasound study of arm or leg veins with compression and maneuvers2937$166
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more2626$145
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2447$105
93971Ultrasound study of one arm or leg veins with compression and maneuvers1549$103
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3094$74

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MethylprednisoloneMethylprednisolone1696$157
GabapentinGabapentin12420$78

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$73Cumberland Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amir Karam Issa, MD?

Tedicare shows public-source Medicare data for Amir Karam Issa, MD (NPI 1386110799), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amir Karam Issa, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amir Karam Issa, MD?

Amir Karam Issa, MD is linked to CURA MEDICAL GROUP LLC (billing NPI 1154068401) in the available physician profile data.

Does Amir Karam Issa, MD have Open Payments data?

Amir Karam Issa, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.